Kiniksa Pharmaceuticals International, plc KNSA Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's accretion (amortization) of discounts and premiums, investments?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported accretion (amortization) of discounts and premiums, investments of -$1.3M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's accretion (amortization) of discounts and premiums, investments decreased by 410.6% year-over-year, from -$255K to -$1.3M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's accretion (amortization) of discounts and premiums, investments?
- Over 2 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's accretion (amortization) of discounts and premiums, investments has grown at a 17.5% compound annual growth rate (CAGR), from -$664K to $916K.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This represents the non-cash adjustment to the carrying value of debt or investment securities resulting from the amortization of premiums or the accretion of discounts over the life of the instrument. It aligns the effective interest rate of the financial asset or liability with the stated coupon rate. Monitoring this helps analysts understand the non-cash components of interest income or expense that affect net earnings.